Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Hydrocodone/Acetaminophen |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 500mg BID or 850mg qam c cib |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Start with 5mg qday, max dose 10mg qday |
|
|
Term
|
Definition
| 0.25-0.5mg TID (initial dose) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 10-80mg qday (usually in the PM) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 50-100mg q4-6 hours prn pain (max 400mg/day) |
|
|
Term
|
Definition
| 16-80mEq qday in 1-2 doses |
|
|
Term
| Hydrochlorothiazide (HCTZ) |
|
Definition
| 25-100mg qday in 1-2 doses |
|
|
Term
|
Definition
| 20mg BID or 30mg BID or 60mg qday |
|
|
Term
|
Definition
| 150mg per day, initially in divided doses |
|
|
Term
|
Definition
| 100-450mg qday in 1-2 doses |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 10mg TID (immediate release form) or 30mg qday (ER form) |
|
|
Term
|
Definition
|
|
Term
| Fluticasone Propionate (nasal) |
|
Definition
| Two sprays in each nostril qday |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 300-400mg qday in 2-3 doses or 1 ER tab |
|
|
Term
| Fluticasone Propionate and Salmeterol Xinafoate |
|
Definition
| 1 diskus or 2 HFA inhalations q12 hours |
|
|
Term
| Insulin Glargine, rDNA Origin |
|
Definition
| No typical dose; unique to pt |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 10-40mg qday, max 80mg qday |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Tiotropium Bromide (inhalation) |
|
Definition
| 1 cap qday with HandiHaler device |
|
|
Term
|
Definition
| 2-6mg qday in divided doses |
|
|
Term
|
Definition
| 40-150mg qday in divided doses, or 40-150mg qhs |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 75mg in 2-3 doses (immediate release) or qday (XR) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 10-20mg BID if not already taking opioids |
|
|
Term
|
Definition
| 200-400mg in 2 divided doses |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Individualized dosing (5-60mg/day) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Start with 10mg qday, gradually increase to 20mg/qday |
|
|
Term
| Ipratropium Bromide and Albuterol Sulfate |
|
Definition
| One 3mL vial via nebulizer or 2 sprays from MDI QID |
|
|
Term
|
Definition
| 500mg for 1 day, then 250mg for 4 days |
|
|
Term
|
Definition
| 40mg qday for up to 8 weeks |
|
|
Term
|
Definition
| 250mg TID (IR) or 25mg/kg (ER) qday |
|
|
Term
| Morphine Sulfate (extended release) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Fenofibrate (nanocrystallized) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Begin dose at 75mg BID or 50mg TID |
|
|
Term
|
Definition
| Begin with 1mg BID; for maintenance use lowest effective dose |
|
|
Term
|
Definition
|
|
Term
| Amphetamine and Dextroamphetamine Salts |
|
Definition
| Adults: 20mg extended-release qday |
|
|
Term
|
Definition
| 1200-3200mg in 3-4 divided doses |
|
|
Term
|
Definition
|
|
Term
| Oxybutynin Chloride (oral) |
|
Definition
| Start with 5mg ER tab qday |
|
|
Term
|
Definition
2-10mg tab 2-4 times a day
2-10mg PO, IM, IV, repeat in 3-4h if needed |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Initially 100mg qday, adjust at 5 day intervals to 25-200mg qday |
|
|
Term
|
Definition
|
|
Term
| Nitroglycerin (SL and INJ) |
|
Definition
| Dissolve 1 tab under tongue or in buccal pouch at first sign of acute anginal attack |
|
|
Term
|
Definition
| 5-10mg up to four times per day |
|
|
Term
|
Definition
|
|
Term
| Insulin Aspart (rDNA Origin) |
|
Definition
| Dosage must be individualized |
|
|
Term
|
Definition
| 10mg per day or 70mg per week |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 15-45mg per day for maintenance dose |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Sulfamethoxazole and Trimethoprim |
|
Definition
| 800mg/160mg q12h for 10-14 days |
|
|
Term
|
Definition
| Patches should be left on for 12 hours within a 24 hour period, may be cut into smaller sizes as needed |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Budesonide and Formoterol Fumarate Dihydrate (Inhalation) |
|
Definition
|
|
Term
|
Definition
| Starting dose of 500mg BID |
|
|
Term
|
Definition
| Adults: 250-500mg q8h or 500-875mg q12h |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 5-10mg 30 mins before each meal and QHS for 2-8 weeks |
|
|
Term
|
Definition
| 80mg per day in single or divided dose, up to 50mg qday in divided doses -OR- 120-160mg qday (sustained release) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 50-100mg up to four times a day |
|
|
Term
|
Definition
| Apply liberally to affected areas 2-3 times per day |
|
|
Term
|
Definition
| 5mg BID a breakfast & lunch, gradual increase of 5-10mg weekly |
|
|
Term
|
Definition
| 1-4mg qday, max 8mg daily |
|
|
Term
|
Definition
| 20-40mg BID for 6-12 weeks |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Start with 0.05 system applied to trunk of body, changed twice weekly |
|
|
Term
| Pramipexole Dihydrochloride |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 4mg daily in one (LA cap) or two (tab) doses |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 250-500mg q12h (immediate release) |
|
|
Term
|
Definition
|
|
Term
|
Definition
| One patch applied topically and replaced q72h |
|
|
Term
|
Definition
| Dosage must be individualized |
|
|
Term
|
Definition
| 7.4-30mg given 30 minutes before bedtime |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 30mg daily before a meal, up to 8 weeks |
|
|
Term
|
Definition
|
|
Term
| Mometasone Furoate Monohydrate (intranasal) |
|
Definition
| Two sprays in each nostril qday |
|
|
Term
|
Definition
| 800-1200mg in 3-4 divided doses |
|
|
Term
|
Definition
| Starting dose of 5mg qday |
|
|
Term
| Phenytoin Sodium (extended) |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| One-half to one SR tab qAM, 1 SR tab q12h, or 1 DR capsule QHS |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 150mg as a single po dose |
|
|
Term
| Triamcinolone Acetonide (topical) |
|
Definition
| Apply to affected areas 2-4 times a day |
|
|
Term
| Conjugated Estrogens (systemic) |
|
Definition
|
|
Term
|
Definition
| Starting dose of 2mg (non-elderly) or 1mg (elderly) qhs |
|
|
Term
| Insulin Lispro (rDNA Origin) |
|
Definition
| Dosage must be individualized |
|
|
Term
|
Definition
| 0.63mg administered via nebulizer TID every 6-8 hours |
|
|
Term
| Niacin (extended release) |
|
Definition
| Start with 500mg qhs for 4 weeks |
|
|
Term
|
Definition
| 5-40mg qday in single or divided doses |
|
|
Term
| Omega-3-Acid Ethyl Esters |
|
Definition
| 4 grams qday in 1-2 divided doses with meals |
|
|
Term
|
Definition
| Dosage must be individualized |
|
|
Term
|
Definition
| 50mg qday with or without food |
|
|
Term
|
Definition
| 1-4mg one to two times a day |
|
|
Term
| Butalbital, Acetaminophen, and Caffeine |
|
Definition
|
|
Term
|
Definition
| 600mg BID 30 mins before morning and evening meals |
|
|
Term
| Fluticasone Propionate (inhalation) |
|
Definition
|
|
Term
| Losartan Potassium with HCTZ |
|
Definition
|
|
Term
|
Definition
| 0.5-2mg qday in 1-2 divided doses |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 25-100mg with fluids at the first sign of migraine attack |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 50mg TID-QID, 75mg BID, or 100mg XR qday-BID |
|
|
Term
|
Definition
|
|
Term
| Chlorpheniramine with Hydrocodone |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 10-25mg per week until adequate response achieved |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 1 capsule BID (morning and evening) |
|
|
Term
| Amoxicillin with Clavulanate Potassium |
|
Definition
| 500mg/125mg IR q8h or 875mg/125mg IR q12h |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 2.5-20mg qday in 1-2 divided doses |
|
|
Term
| Acetaminophen with Codeine Phosphate |
|
Definition
| One to two #2 or #3 tablets q4h prn |
|
|
Term
| Ezetimibe with Simvastatin |
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| 1 gtt in affected eye(s) qday in evening |
|
|
Term
| Amlodipine Besylate with Benazepril HCl |
|
Definition
|
|
Term
|
Definition
| 1 gram QID on an empty stomach |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Olopatadine HCl (Ophthalmic) |
|
Definition
| 1 gtt in affected eye(s) BID at an interval of 6-8h |
|
|
Term
|
Definition
| 100mg cap q12h for 7 days |
|
|
Term
|
Definition
| 200mg po q4h while awake (5 caps/day for 10 days) |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
| Promethazine HCl with Codeine Phosphate |
|
Definition
| One teaspoonful every 4-6 hours |
|
|
Term
| Diclofenac Sodium (topical) |
|
Definition
| Apply 2 grams to affected area of upper extremity, or 4g to lower extremity up to 4 times a day |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Post-titration maintenance dose: 250mg TID-QID |
|
|
Term
| Hydroxychloroquine Sulfate |
|
Definition
|
|
Term
|
Definition
| 75-150mg per day in single or multiple doses |
|
|
Term
|
Definition
|
|
Term
|
Definition
| Starting dose: 2-4mg PO q4-6h |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Dosage must be individualized, may range from 4-48mg qday |
|
|
Term
|
Definition
|
|
Term
|
Definition
| 15-150mg per day in 3-4 divided doses |
|
|
Term
|
Definition
| 60mg qday without regard to meals or time of day |
|
|
Term
|
Definition
|
|
Term
| Diphenoxylate HCl with Atropine Sulfate |
|
Definition
| 2 tabs or 2 teaspoonfuls of liquid QID until diarrhea is under control |
|
|
Term
| Clotrimazole with Betamethasone Dipropionate |
|
Definition
| AAA BID in the morning and evening for up to 2 weeks |
|
|
Term
|
Definition
|
|
Term
|
Definition
|
|
Term
|
Definition
| Initial recommended dose in patients without renal impairment: 80mg BID |
|
|
Term
|
Definition
| Two sprays in each nostril BID |
|
|
Term
|
Definition
|
|
